Company / Capital Returned to Shareholders
Indivior Capital Returned to Shareholders History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$11.0M
FY2025
5-year range
$11.0M / $173.0M
FY2022-FY2025
Trend
-93.6%
vs FY2024
Sector context
#42 of 52
Health Care
What the data says
Indivior's capital returned to shareholders of $11M is lower than 81% of companies in the Health Care sector (FY2025). Declined from $33M to $11M over the past 2 years.
Based on SEC 10-K filings.
$11M in FY2025 with a 3-year CAGR of -50.4%.
Declined from $33M to $11M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -50.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 52This company $11.0M Sector average $1.3B
▼
-99.2% below sector average
Key checks
Key Insights
- 3-year CAGR of -50.4%, indicating a declining trend.
- In FY2025, capital returned to shareholders decreased 93.6% year-over-year.
- Ranks #42 out of 52 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.0M | -93.6% |
| FY2024 | $173.0M | +424.2% |
| FY2023 | $33.0M | -63.3% |
| FY2022 | $90.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026